 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
Will Insurers Cover $700 for Myriad's Large Rearrangement Test Plus $3K for BRACAnalysis?
August 15, 2012
Will Insurers Cover $700 for Myriad's Large Rearrangement Test Plus $3K for BRACAnalysis?
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- After Appeals Court Victory, Myriad Looks to Debunk 'Misconceptions' on How it Enforces DNA Patents
August 22, 2012 / Pharmacogenomics Reporter - Patents, Regulation, Reimbursement: Myriad Reflects on Impact of Key Events on Future Business
November 3, 2010 / Pharmacogenomics Reporter - Healthcare Providers Petition Myriad to Add Large Rearrangement Analysis to Standard BRACAnalysis
August 3, 2011 / Pharmacogenomics Reporter - Despite Impending Challenges, Myriad Offers Rosy Projections at Investor Conference
September 22, 2010 / Pharmacogenomics Reporter - Myriad 'Aggressively' Eyeing M&A, Companion Dx Deals, Euro Opportunities in FY 2011
August 11, 2010 / Pharmacogenomics Reporter